HomeXERS • NASDAQ
Xeris Biopharma Holdings Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 60.10M | 35.39% |
Operating expense | 42.84M | -8.18% |
Net income | -5.11M | 61.81% |
Net profit margin | -8.51 | 71.78% |
Earnings per share | -0.03 | 70.00% |
EBITDA | 10.80M | 259.24% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.62M | -1.15% |
Total assets | 323.06M | 0.14% |
Total liabilities | 352.68M | 7.07% |
Total equity | -29.62M | — |
Shares outstanding | 153.94M | — |
Price to book | -22.80 | — |
Return on assets | 6.04% | — |
Return on capital | 8.03% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.11M | 61.81% |
Cash from operations | 1.98M | -73.56% |
Cash from investing | 10.02M | -32.63% |
Cash from financing | 398.00K | 132.25% |
Net change in cash | 12.39M | -41.30% |
Free cash flow | 14.08M | 26.05% |
Previous close
$4.56
Day range
$4.50 - $4.89
Year range
$1.69 - $4.89
Market cap
702.92M USD
Avg Volume
2.54M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Headquarters
Website
Employees
394
